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GABA type A receptors (GABAARs) mediate fast synaptic in-
hibition and are trafficked to functionally diverse synapses.
However, the precise molecular mechanisms that regulate the
synaptic targeting of these receptors are unclear.Whereas it has
been previously shown that phosphorylation events in a4, b,
and g subunits of GABAARs govern their function and traffick-
ing, phosphorylation of other subunits has not yet been demon-
strated. Here, we show that the a2 subunit of GABAARs is
phosphorylated at Ser-359 and enables dynamic regulation of
GABAAR binding to the scaffolding proteins gephyrin and colly-
bistin. We initially identified Ser-359 phosphorylation by MS
analysis, and additional experiments revealed that it is regulated
by the activities of cAMP-dependent protein kinase (PKA) and
the protein phosphatase 1 (PP1) and/or PP2A. GST-based pull-
downs and coimmunoprecipitation experiments demonstrate
preferential binding of both gephyrin and collybistin toWT and
an S359A phosphonull variant, but not to an S359Dphosphomi-
metic variant. Furthermore, the decreased capacity of the a2
S359D variant to bind collybistin and gephyrin decreased the
density of synaptic a2-containing GABAAR clusters and caused
an absence of a2 enrichment in the axon initial segment. These
results suggest that PKA-mediated phosphorylation and PP1/
PP2A-dependent dephosphorylation of the a2 subunit play a
role in the dynamic regulation of GABAAR accumulation at in-
hibitory synapses, thereby regulating the strength of synaptic
inhibition. The MS data have been deposited to ProteomeX-
change, with the data set identifier PXD019597.
GABAARs mediate fast synaptic inhibition, the efficacy of
which is determined by the number of inhibitory synapses (1,
2). GABAARs are ligand-gated chloride channels that form het-
eropentamers assembled from a combination of several subu-
nits, including a1-6, b1–3, g1–3, d, e, u, and p (3). However,
most synaptic GABAARs comprise two a1, a2, or a3 subunits,
two b2 or b3 subunits, and one g2 subunit (3, 4). Each subunit
is composed of a large N-terminal domain, four transmem-
brane (TM) domains, and a large intracellular loop between
TM3 and TM4 that is the site of multiple protein-protein inter-
actions (5–7). Despite the high structural homology between
GABAAR a-subunits, they are selectively targeted to distinct
types of inhibitory synapses. Indeed, a2-containing GABAAR
are enriched at synapses on the axon initial segment (AIS),
whereas a1-containing receptors are more evenly distributed
between the AIS and dendrites (8, 9). It has been proposed that
the a-subunits play key roles in the selective subcellular targeting
of GABAARs (10). However, the molecular mechanisms that reg-
ulate precise targeting of these receptors remain unknown.
Post-translational modification is one mechanism by which
GABAARs are regulated. Notably, the phosphorylation of key
residues on GABAARs have been previously shown to regulate
protein interactions that govern trafficking and surface stability
of receptors (11, 12); however, phosphorylation of GABAAR a2
subunit has not been demonstrated, and its significance is yet
to be determined (13).
Protein interactions fundamental to receptor clustering at
the postsynaptic domain include GABAAR a2 subunit interac-
tions with gephyrin and collybistin. Gephyrin is the canonical
inhibitory synaptic scaffold protein that is highly enriched at
GABAergic postsynapses, where it colocalizes with synaptic
GABAARs (14). The critical role for gephyrin in the formation
of postsynaptic inhibitory synapses was highlighted through
the utilization of knockout and RNAi tools, which demon-
strated the loss of gephyrin and subsequent loss of synaptic
GABAAR clusters (15, 16). Moreover, GABAAR mutations that
reduce gephyrin binding also result in fewer synaptic clusters
(17). Collybistin is a Rho guanine nucleotide exchange factor
that binds both gephyrin and GABAAR a2 (18). The impor-
tance of collybistin in targeting gephyrin to the inhibitory syn-
apse was demonstrated in collybistin-deficient mice, which ex-
hibit a loss of gephyrin and GABAAR puncta (19). Further,
mutations in GABAARs that disrupt or enhance collybistin
binding resulted in corresponding decreased or increased
GABAAR-containing synapses at the AIS (20, 21).
In this study, we utilizedMS to identify a novel phosphoryla-
tion site at serine 359 on the GABAAR a2 subunit. This residue
is situated in the large intracellular loop between TM3 and
TM4 of the a2 subunit, close to the overlapping binding sites of
gephyrin and collybistin. Ser-359 is phosphorylated by PKA,
and dephosphorylation of this site depends on PP1/PP2A.
Phosphomimetic mutation of this site decreased receptor bind-
ing to both gephyrin and collybistin, resulting in a reduced
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number of synaptic a2 clusters in dendrites and an absence of
a2 enrichment in the AIS. These results show that the phosphor-
egulation of a2 by PKA and PP1/PP2A allows neurons to adjust
the efficacy of gephyrin and collybistin binding, which plays a
fundamental role in regulating the density of inhibitory synapses
at dendrites and the enrichment of inhibitory synapses at the AIS.
Results
Identification of serine 359 on the GABAAR a2 subunit as a
novel phosphorylation site
To identify novel phosphorylation sites on the GABAAR a2
subunit, we utilized previously characterized Myc/pH-sensitive
GFP (pHluorin)-tagged GABAAR a2 subunit (pHa2) knock-in
mice (22). Hippocampi and cortex from age- and sex-matched
WT and pHa2 mice were solubilized and incubated with GFP-
Trap beads to immunoprecipitate pHa2. After extensive
washes, bound material was eluted and subjected to SDS-
PAGE followed by Coomassie staining. An 80 kDa band corre-
sponding to pHa2 was excised and analyzed by LC–MS/MS
(Fig. 1A and Fig. S1). Phosphorylation sites were identified by
the Taplin Facility using the Ascore algorithm (23). Two phos-
phopeptides were identified corresponding to residues Ser-359
and Ser-379 on theGABAAR a2 subunit (Fig. 1, B andC). Phos-
phorylated Ser-359 peptides were found in all four independent
purifications, whereas Ser-379 was only found in one of four
experiments. Both potential phosphorylation sites are located
in the large intracellular loop of the receptor. Further, this site
is conserved in the human, mouse, and rat sequence of the a2
subunit (Fig. 1D). Given the more robust phosphorylation of
Ser-359, we focused on this site.
Phosphorylation of purified GST-a2
To further corroborate our MS findings, in vitro kinase
assays were performed with GST alone or GST fused to the in-
tracellular loop of the GABAAR a2 subunit. Because the kinase
responsible for phosphorylating this site had yet to be identi-
fied, brain lysate was used as a source of kinase. GST, GST-a2
WT, or GST-a2 S359A phosphomutant proteins were incu-
bated with brain lysate and [g-32P]ATP to measure phosphory-
lation levels at this site. Phosphorylation of GST alone was not
detected in these experiments compared with GST-WT and
GST-S359A (p , 0.0001, Fig. 2A). The mutant form of the
GST-a2 subunit, where Ser-359 was converted to an alanine
residue by site-specific mutagenesis, showed significantly
decreased levels of phosphorylation compared with WT (WT,
1.006 0.03; S359A, 0.776 0.03; p = 0.0023). The decrease in
Figure 1. Identification of two novel phosphorylation sites on GABAAR a2 subunit at serine 359 and 379 by LC–MS/MS. A, neuronal lysates from WT
and pHa2 mice were incubated with GFP-Trap and subjected to SDS-PAGE followed by Coomassie staining. The 80 kDa gel band (arrow) corresponding to
pHa2 was excised and digested with both trypsin and chymotrypsin before MS analysis was performed by the Taplin MS Facility. B, GABAAR a2 phosphopep-
tide sequences identified by MS/MS analysis of pHa2, including the SEQUEST scores XCorr (cross-correlation) and DCn (delta correlation), charge state (z), pre-
cursor m/z, and Ascore values (for Ascore. 13, p, 0.05). Phosphorylated serine sites identified are colored red. M*, oxidation of methionine. A period in the
peptide sequence indicates the protease cleavage sites. n = 4.C, MS/MS spectrum of the pHa2 derived for peptide EKGpSVMIQNNAY phosphorylated at Ser-
359. The phosphorylated serine site is marked as pS.M*, oxidation of methionine. The observed b ion (blue) and y ion (red) peptide fragment masses are indi-
cated on the spectrum. D, schematic depicting the GABAAR a2 subunit. The novel phosphorylated serine residues (red) are located between TM domains 3
and 4 on the large intracellular domain. Both identified serine sites are conserved inmice, rats, and humans.
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phosphorylation shown for the GST-a2 S359Amutant strongly
suggests that Ser-359 represents a site of phosphorylation in
the a2 subunit.
Phosphorylation of this site was further examined by phos-
phopeptide map analysis. Two-dimensional phosphopeptide
map analysis revealed two major positively charged phospho-
peptides (red and blue circles, Fig. 2B), one of which corre-
sponds to a phosphopeptide containing a phosphorylated Ser-
359 (red circle). Together, these results support the MS data in
the identification a novel phosphorylation site at Ser-359 in the
GABAAR a2 subunit.
Serine 359 dephosphorylation is PP1/PP2A-dependent
Because kinases present in brain lysate are capable of phos-
phorylating GABAAR a2 at Ser-359, a purified phosphorylation
state–specific antibody directed toward Ser-359 was produced
(PhosphoSolutions). To test the specificity of this antibody,
horizontal slices from 8-week-old male pHa2 animals were
treated for 30 min with 1 mM okadaic acid, a broad-spectrum
inhibitor of protein phosphatase 1 (PP1) and protein phospha-
tase 2A (PP2A). Immunoblotting revealed that the pSer-359
antibody did not recognize thea2 subunit in crude brain lysates
(Fig. 3 (A and B), input lane). Therefore, we first immunopreci-
pitated pHa2 from these lysates with GFP-Trap. Phosphoryla-
tion at Ser-359 was only detected following okadaic acid treat-
ment (no peptide: DMSO, 0.0696 0.07; OA, 1 6 0.08 (p ,
0.0001); nonphosphopeptide: DMSO, 0.00076 0.0007; OA,
0.766 0.08 (p, 0.0001); Fig. 3A). Moreover, detection of the a2
Ser-359 band was prevented by incubation of the phosphoanti-
body with synthetic phospho-Ser-359 peptide (0.006 0.00) com-
pared with no peptide1OA and nonphosphopeptide1OA (no
peptide 1 OA, 1 6 0.07 (p , 0.0001); nonphosphopeptide 1
OA, 0.766 0.08 (p , 0.0001)). However, incubation with non-
phosphorylated Ser-359 peptide showed little interference with
the immunodetection of the phosphorylated a2 subunit (p =
0.058). Together, these data indicate that Ser-359 dephosphory-
lation depends on PP1 and/or PP2A tomaintain phosphorylation
at low levels under basal conditions in themouse brain.
To further validate the phosphoantibody, similar experi-
ments were performed in neuronal cultures. Rat cortical neu-
rons at 19 DIV expressing pHa2WT or S359A phosphomutant
were treated with okadaic acid (Fig. 3B). Similar to the experi-
ments in slices, immunoprecipitationwas required before using
this antibody. Further, okadaic acid led to an increase in Ser-
359 phosphorylation levels (WT2OA, 0.016 0.01; WT1 OA,
1 6 0.05; p , 0.0001), which was abolished in the S359A mu-
tant (SA 1 OA, 0.006 0.00; p , 0.0001). Collectively, these
experiments indicate that we have successfully produced a
phosphospecific a2 Ser-359 antibody. Furthermore, these data
corroborate that phosphorylation of this site is kept at low lev-
els under basal conditions and confirm that its dephosphoryl-
ation is regulated by PP1 and/or PP2A.
PKA activity regulates serine 359 phosphorylation
Next, we investigated which kinase phosphorylates this site.
The web-based kinase prediction tool, NetPhos3.1 (24), pre-
dicted PKA as the potential kinase responsible for Ser-359
phosphorylation. To test this, we performed a kinase assay
incubating the catalytic subunit of PKA with purified GST,
GST-a2 WT, or GST-a2 S359A mutant. Immunoblotting
showed that PKA increased Ser-359 phosphorylation in GST-
a2 WT (WT 2 PKA, 0.006 0.00; WT 1 PKA, 1 6 0.13; p ,
0.0001), which was not seen in GST alone (0.006 0.00, p ,
0.0001) or the GST-a2 S359A phosphonull mutant (0.006 0.00,
p , 0.0001; Fig. 4A). These results demonstrate that PKA can
directly phosphorylate a2 at Ser-359. To corroborate these find-
ings, experiments were performed in neuronal cultures. Cortical
cultures infected with pHa2 WT lentivirus were incubated with
10 mM forskolin (Fsk, 10 min) to activate PKA and/or preincu-
bated with 10 mM myristoylated PKA inhibitor (myr-PKI, 45
min). pHa2 was immunoprecipitated with GFP-Trap, and im-
munoblots were incubated with phospho-Ser-359 antibody to
determine relative phosphorylation levels. Incubation of neurons
with Fsk led to an increase in phospho-Ser-359 pHa2 levels
(2Fsk, 0.016 0.01; 1Fsk, 1 6 0.05; p , 0.0001), which was
blocked by the PKA-specific inhibitor myr-PKI (1myr-PKI 1
Fsk, 0.006 0.00; p , 0.0001; Fig. 4B), further suggesting that
phosphorylation of Ser-359 in neurons is regulated by PKA
activity.
Phosphomimetic a2 S359D intracellular loop domain binds
less gephyrin and collybistin in vitro
Intriguingly, the Ser-359 site is near or within the gephyrin-
and collybistin-binding site in the a2 subunit (Fig. 5A) (18). We
Figure 2. Kinases present in brain lysate phosphorylate GABAAR a2 at Ser-359. A, GST alone or GST fused to the intracellular loop of the a2 subunit (WT
or S359A) was labeled with 10 mCi of 32P and incubated with brain lysate as a source of kinase for 7 min at 30 °C. Fusion proteins were then subjected to SDS-
PAGE and visualized with autoradiography (left). Right, quantification of 32P incorporation. Data are means 6 S.E. (error bars). **, p , 0.01; ****, p , 0.0001;
one-way ANOVA, Tukey’s post hoc test, n = 3. B, phosphopeptide map of GST-a2 WT and S359A. 32P-Labeled a2 bands from Awere excised, trypsinized, blot-
ted on TLC plates, and subjected to electrophoresis followed by ascending chromatography. Colored circles represent the twomajor tryptic peptides found in
GST-a2WT. The red circle highlights a tryptic peptide in GST-a2WT that is missing in S359A. The blue circle highlights a tryptic peptide in GST-a2WT that is still
present in S359A.
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therefore asked whether Ser-359 phosphorylation affected their
interaction with GABAAR a2. Pulldown assays were performed
utilizing GST or GST fused to the large intracellular loop of
GABAAR a2 WT, S359A phosphonull, or S359D phosphomi-
metic mutants to investigate binding of gephyrin and collybis-
tin. Purified GST fusion proteins were incubated with deter-
gent-solubilized rat cortical neuronal lysates and subjected to
immunoblotting. All GST-a2 subunit loop domains bound to
gephyrin or collybistin compared with GST alone (gephyrin:
WT, p , 0.0001; SA, p , 0.0001; SD, p = 0.021; collybistin:
Figure 3. Application of okadaic acid increases phosphorylation of GABAAR a2 Ser-359 in pHa2 mice. A, horizontal brain slices from pHa2 mice were
treated with OA (1 mM) or DMSO vehicle control for 30 min. These brain lysates were then used to immunoprecipitate pHa2 and immunoblot for phosphory-
lated a2 at Ser-359 (a2 pS359). Blots were incubated with a2 pS359 antibody alone (No peptide), or a2 pS359 antibody incubated with synthetic phosphory-
lated Ser-359 peptide (Phosphopeptide) or nonphosphorylated Ser-359 peptide (Non-phosphopeptide). Data are means 6 S.E. (error bars). ****, p , 0.0001;
one-way ANOVA, Tukey’s post hoc test, n = 3. B, rat cortical neurons were infected at 15 DIV with lentivirus expressing pHa2 WT or the S359A mutant. At 19
DIV, neurons were treated with OA (1 mM) or DMSO vehicle control for 30 min. Cell lysates were subjected to immunoprecipitation with GFP-Trap, and immu-
noblots were incubated with a2 or a2 pSer-359 antibody. Data are means6 S.E. ****, p, 0.0001; one-way ANOVA, Tukey’s post hoc test, n = 4.
Figure 4. PKA phosphorylates GABAAR a2 at Ser-359. A, GST, GST-a2WT, or GST-a2 S359A was incubated with the catalytic subunit of PKA and ATP at 30 °
C for 30 min. Samples were washed and immunoblotted for pSer-359. Data are means6 S.E. (error bars). ****, p, 0.0001; one-way ANOVA, Tukey’s post hoc
test, n = 4. B, cortical neurons were transduced at 15 DIV with lentivirus expressing pHa2. At 19 DIV, neurons were incubated with Fsk (10 mM, 15 min) and/or
pretreated with myr-PKI (10 mM, 35 min). Cell lysates were subjected to immunoprecipitation with GFP-Trap, and immunoblots were incubated with a2 pSer-
359 or GFP antibody. Data aremeans6 S.E. ****, p, 0.0001; one-way ANOVA, Tukey’s post hoc test, n = 3.
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WT, p , 0.0001; SA, p , 0.0001; SD, p = 0.046). However,
gephyrin binding to the S359D mutant was significantly
reduced (0.246 0.03) compared withWT (Fig. 5B, 1.006 0.06,
p , 0.0001) and S359A intracellular loops (1.196 0.07, p ,
0.0001). Alternative splicing generates multiple collybistin iso-
forms that exhibit apparent molecular masses between 50 and
70 kDa, and consistent with other studies, both bands were
included in our analysis (25, 26). This approach revealed that
significantly more collybistin bound WT and S359A (Fig. 5C,
WT, 1.006 0.17 (p = 0.011); SA, 0.996 0.10 (p = 0.012)) com-
pared with S359D mutant (0.456 0.19). These data indicate
that phosphorylation at Ser-359 reduces gephyrin and collybis-
tin binding to a2.
Full-length a2 S359D binds less gephyrin and collybistin in
neurons
We next explored the effects of the Ser-359 mutations in
neurons. Cortical neurons were infected at 15 DIV with either
an shRNA control lentivirus or one that knocked down endoge-
nous GABAAR a2 (Fig. S2). Neurons were co-infected with ei-
ther a GFP control virus or a virus expressing shRNA-resistant
WT, S359A, or S359D forms of full-length pHa2. At 19 DIV,
neuronal lysates were incubated with GFP-Trap and immuno-
blotted for bound proteins. Gephyrin (WT, p = 0.0003; SA, p =
0.0001; SD, p = 0.033; Fig. 6A) and collybistin (WT, p, 0.0001;
SA, p, 0.0001; SD, p = 0.0006; Fig. 6B) coimmunoprecipitated
significantly with pHa2 WT, pHa2 S359A, and pHa2 359D
over GFP alone. Consistent with our GST-pulldown experi-
ments, gephyrin bound WT (1.06 0.04, p = 0.018) and S359A
(1.136 0.14, p = 0.005) significantly more than S359D
(0.486 0.12). Further, collybistin also boundWT (1.06 0.11, p
= 0.0025) and S359A (1.106 0.06, p = 0.0003) more than
S359D (0.566 0.07). In both experiments, WT and S359A
bound gephyrin (p = 0.76) and collybistin (p = 0.74) with similar
efficiencies. Together these data support GST results and dem-
onstrate that Ser-359 phosphomimetic binds gephyrin and col-
lybistin less efficiently thanWT and S359A phosphonull pHa2,
suggesting that phosphorylation reduces binding of gephyrin
and collybistin to a2.
Ser-359 phosphorylation regulates pHa2 cluster density and
AIS enrichment of a2-containing GABAARs
Our data show that phosphorylation at Ser-359 reduces
binding to gephyrin and collybistin, both of which are crucial
for GABAAR a2 synaptic clustering. To assess how synaptic
clustering is affected, neurons were transfected with pHa2
WT, S359A, or S359D at 15 DIV and fixed at 19 DIV. Neurons
were stained for GFP, gephyrin, and ankyrin G, a marker for the
Figure 5. Phosphomimetic mutation of a2 Ser-359 reduces binding to gephyrin (Gphn) and collybistin (Cb) in vitro. A, schematic illustrating a small
section of the large intracellular loop of the GABAAR a2 subunit. The gephyrin- and collybistin-binding sites are shown, and the Ser-359 phosphorylation site
is depicted in blue. B and C, detergent-solubilized cortical neuronal lysates were incubated with GST alone, GST-a2 WT, S359A phosphonull, or S359D phos-
phomimetic mutants. Bound proteins including gephyrin and collybistin were detected by immunoblotting. The bottom panels show Ponceau staining illus-
trating the amounts of GST utilized. Right, graphs show quantification of immunoblots. *, p , 0.05; ****, p , 0.0001; one-way ANOVA with Tukey’s post hoc
test, n = 5. Data are means6 S.E. (error bars).
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AIS. Gephyrin staining was much less prominent on the AIS
compared with dendrites as reported previously (Fig. 7A) (27).
There were no differences in themedian area of pHa2-contain-
ing GABAAR clusters in the AIS (WT, 0.16 (IQR 0.12–2.1); SA,
0.16 (IQR 0.11–0.21); SD, 0.17 (IQR 0.11–0.20); p = 0.86; Fig.
7B) or dendrites (WT, 0.16 (IQR 0.12–0.20); SA, 0.16 (IQR
0.13–0.20); SD, 0.15 (IQR 0.11–0.20); p = 0.078; Fig. 7D)
between conditions. However, the density of pHa2 puncta was
significantly different between conditions in both the AIS and
in dendrites. In the AIS, pHa2 cluster density/mm was signifi-
cantly higher in WT (0.476 0.03, p = 0.002)– and S359A
(0.436 0.03, p = 0.016)–expressing compared with S359D
(0.306 0.03)–expressing neurons (Fig. 7C). Moreover, in den-
drites, pHa2 cluster density/mmwas also significantly higher in
WT (0.326 0.03, p = 0.025)– and S359A (0.326 0.02, p =
0.031)–expressing compared with S359D (0.246 0.02)–
expressing neurons (Fig. 7E). As expected, pHa2 cluster den-
sity/mm was enriched in the AIS compared with dendrites in
pHa2 WT-expressing neurons (AIS, 0.476 0.03; dendrite,
0.326 0.03; p = 0.0003; Fig. 7F). This enrichment of pHa2 in
the AIS was still present in S359A (AIS, 0.436 0.03; dendrite,
0.326 0.02; p = 0.010)–expressing but was lost in S359D (AIS,
0.306 0.03; dendrite, 0.246 0.02; p = 0.38)–expressing neu-
rons. Together these data suggest that the decreased binding to
gephyrin and collybistin observed in pHa2 S359D results in
fewer pHa2 clusters in both the dendrites and AISs. Further-
more, the enrichment of a2-containing GABAAR clusters in
the AIS is lost upon phosphorylation of Ser-359.
Discussion
Identification of Ser-359 as a novel phosphorylation site on
the GABAAR a2 subunit
Efficient phasic inhibition requires the accumulation of spe-
cific GABAAR subtypes at precise postsynaptic specializations.
To determine the contribution of phosphorylation to this pro-
cess, we examined whether the GABAAR a2 subunits were
phosphorylated endogenously by utilizing a previously charac-
terized pHa2 mouse that allows rapid receptor purification
using GFP-Trap (22). MS analysis identified novel phosphoryl-
ation sites at Ser-359 and Ser-379 within the predicted major
intracellular domain of theGABAAR a2 subunit. Notably, these
sites flank the collybistin- and gephyrin-binding site (18). Our
studies focused on Ser-359 as its phosphorylation was more
reproducibly detected compared with Ser-379.
Ser-359 dephosphorylation is PP1/PP2A-dependent
To further study a2 phosphorylation, we created a phospho-
specific antibody against Ser-359. Application of okadaic acid
to brain slices from pHa2 mice showed that blocking PP1/
PP2A led to a marked increase in endogenous a2 Ser-359 phos-
phorylation detected using this antibody. Additionally, in neu-
ronal culture, this increase in phosphorylation by OAwas com-
pletely abolished in the phosphomutant S359A, highlighting
the specificity of this newly developed antibody and confirming
Ser-359 as the first phosphorylation site identified in the a2
subunit (13). These experiments also demonstrated that a2
Ser-359 phosphorylation is continuously maintained at low lev-
els under basal conditions by constitutive cycles of phosphory-
lation and dephosphorylation. Potentially, this mechanism
would allow neurons to rapidly control inhibitory synaptic re-
ceptor content and fine-tune synaptic responsiveness by
dynamically altering the balance between these opposing
processes.
Ser-359 phosphorylation is regulated by PKA
GST-a2 kinase assays demonstrated that Ser-359 is directly
phosphorylated by PKA. These results were corroborated in
neurons, where PKA activation by forskolin led to increases in
phosphorylation that were abrogated by the addition of the
PKA-specific inhibitormyr-PKI.
Interestingly, PKA and PP1/PP2A have been previously
implicated in the regulation of GABAARs through phosphoryl-
ation of the b3 subunit, which forms receptors with a2 (3, 28),
to control receptor surface expression (29–31). However, how
multiple phosphorylation sites on various subunits are inde-
pendently regulated, and how this influences the fate of the
assembled receptors, remains to be established. Potentially,
proteins that facilitate phosphorylation and dephosphorylation,
such as protein kinase A–anchoring protein 79/150 (AKAP70/
150), receptor-activated protein kinase C 1 (RACK1), and phos-
pholipase C–related inactive protein type 1 (PRIP1) may assist
in the precise spatio-temporal targeting of kinases and phos-
phatases to specific receptor subunits (31–33), although further
work will be required to address this possibility directly.
Figure 6. Phosphomimetic mutation of a2 Ser-359 reduces gephyrin
(Gphn) and collybistin (Cb) binding in neurons. Cortical neurons were
infected at 15 DIV with lentivirus expressing GFP, pHa2 WT, S359A, or S359D.
These neurons were co-infected with lentivirus expressing a control shRNA
(for GFP control) or shRNA targeting endogenous a2 (for WT, SA, and SD). At
19 DIV, lysates were subjected to immunoprecipitation with GFP-Trap beads,
and coimmunoprecipitated proteins gephyrin (A) (n = 3) and collybistin (B) (n
= 5) were detected by immunoblotting. Graphs (right) are quantification of
immunoblots (left). *, p , 0.05; **, p , 0.01; ***, p , 0.001; one-way ANOVA
with Tukey’s post hoc test. Data are means6 S.E. (error bars).
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GABAAR a2 S359D phosphomimetic mutant binds less
efficiently to gephyrin and collybistin
Because the a2 Ser-359 phosphorylation site was near the
gephyrin- and collybistin-binding site, we next addressed the
role of phosphorylation at this site using in vitro binding assays
as well as immunoprecipitation. As evidenced by binding
assays, both gephyrin and collybistin bound preferentially to
GST-a2 WT and the S359A phosphonull mutant compared
with the S359D phosphomimetic. Considering that the phos-
phorylation of this site is kept at low levels, we might expect
WT and S359A to behave in a similar fashion. Correspondingly,
when pHa2 was immunoprecipitated from neuronal lysates,
levels of coimmunoprecipitation of both gephyrin and collybis-
tin were reduced in S359D phosphomimetic mutants com-
pared withWT and S359A phosphonull mutants.
pHa2 WT and S359A phosphonull expressing neurons have a
higher density of a2 clusters in dendrites and AISs
Because previous studies have shown that decreased binding
to gephyrin and collybistin resulted in a decreased density of
clusters of a1-containing GABAARs in dendrites and a2-con-
taining GABAARs in the AIS, respectively (17, 20), we decided
to ascertain the consequences of phosphorylation on the synap-
tic accumulation of GABAAR a2 by measuring the size and
density of pHa2 clusters in different neuronal domains.
Although there was no difference in cluster area, there were sig-
nificant differences in cluster density. In both the AISs and den-
drites, there was a decrease in pHa2 cluster density with S359D
phosphomimetic mutant, compared with WT and S359A mu-
tant, which we attribute to the fact that S359D has a decreased
capacity to bind both collybistin and gephyrin. In dendrites, the
fewer synaptic a2 puncta observed in S359D-expressing neu-
rons is likely attributable to the decrease in gephyrin’s ability to
mediate the transient stabilization of these receptors at the syn-
apse, as previously observed in a1 mutants with compromised
binding to gephyrin (17). The decrease in a2 clustering at the
AIS is likely due to decreased collybistin binding, because the
S359D mutant displays a similar loss of AIS clusters to that
reported for an a2 mutant with decreased ability to bind colly-
bistin (20). Moreover, gephyrin-a2 subunit associations are
weaker at the AIS, indicating that gephyrin has a comparatively
minor role in AIS clustering of a2-containing GABAARs (34).
Indeed, this seems to be the case in our study, as we also noticed
a previously reported (27) lower-intensity gephyrin staining in
the AIS compared with dendrites.
Collybistin immunostaining is technically challenging, but
published studies suggest that this protein is not exclusively
found at synapses or at the AIS; rather, it is associated with in-
tracellular membranes throughout the cells (20). Thus, colly-
bistin may not act as a simple scaffold protein but may regulate
GABAAR intracellular trafficking to facilitate its targeting to
synapses.
Enrichment of a2 in the AIS is lost in pHa2 S359D
phosphomimetic-expressing neurons
Consistent with a previous report (8), we observed an enrich-
ment of a2 clusters at the AIS compared with dendrites. Fur-
ther, this enrichment is maintained in pHa2 S359A but lost in
S359D-expressing neurons, suggesting that a2 S359D is found
at similar levels in both dendrites and the AIS and that phos-
phorylation of this site limits the enrichment of a2 clusters nor-
mally observed at the AIS. Thus, this residue appears to reduce
the stability of a2-GABAARs at synaptic sites across the neu-
ron, including at the AIS. This novel regulatory mechanism
sheds light on the ways in which neurons control inhibitory
neurotransmission.
GABAergic neurotransmission must be tightly and precisely
controlled to shape excitatory neurotransmission and generate
normal network activity patterns. In the absence of such con-
trol, pathological hyperexcitability can result (20, 35–37). In
the case of Ser-359, the phosphoregulation of this site would
allow neurons to rapidly alter the affinity of a2-containing
GABAARs for their stabilization at synapses; thus, neurons
could rapidly respond to local changes in their own excitability
and the excitability of the network around them, fine-tuning
the density of a2-GABAAR synaptic clusters and adjusting the
inhibitory drive according to their present circumstances. This
novel mechanism for rapid response becomes even more inte-
gral as it pertains to inhibition at the AIS. The AIS is the site of
action potential generation (38), and inhibitory neurotransmis-
sion in this area—almost exclusively mediated by synaptic a2-
GABAARs—has a tremendous effect on neuronal excitability
(8, 39, 40). Furthermore, the AISs of forebrain pyramidal neu-
rons, such as the ones studied here, are solely innervated by in-
hibitory chandelier cell interneurons (41). Each chandelier cell
is thought to innervate the AISs of hundreds of pyramidal cells,
allowing for the coordination of activity across large networks
and giving rise to oscillatory activity (42–44). Further, we have
previously shown that disturbing the stability of a2-GABAARs
at axo-axonic synapses has large consequences for inhibitory
neurotransmission and network excitability (20, 21).
In summary, we have identified that phosphorylation of Ser-
359 within the a2 subunit acts to reduce the binding to the in-
hibitory scaffold molecules collybistin and gephyrin, resulting
in reduced GABAAR accumulation at synapses. This novel reg-
ulatory mechanism may allow neurons to fine-tune the activity
of a subset of synapses enriched in a2 subunit-containing
GABAARs.
Figure 7. Phosphomimetic mutations of a2 Ser-359 reduce pHa2 cluster density in neurons. A, top, hippocampal neurons transfected at 15 DIV with
pHa2 WT, S359A, or S359D and fixed at 19 DIV. Neurons were stained with anti-GFP (green), anti-gephyrin (red), and anti-ankyrin G (blue) antibodies. Scale bar,
20 mm.White boxes aremagnified in the images below depicting a 20-mm section of AIS and dendrite. B and D, quantification of pHa2 cluster area in the AIS
and dendrites, respectively. Box-and-whisker plots, minimum, lower quartile, median, upper quartile, andmaximum values; Kruskal–Wallis test. C and E, quanti-
fication of pHa2 cluster density in the AIS and dendrite, respectively. Data are means6 S.E. (error bars) *, p, 0.05; **, p, 0.01; one-way ANOVA with Tukey’s
post hoc test. F, quantification of pHa2 cluster density in the AIS (A) and dendrite (D) as shown in C and E. n = 3 individual cell culture preparations (AIS: 18 WT,
21 SA, and 14 SD cells; dendrite: 19 WT, 17 SA, and 18 SD cells). Data aremeans6 S.E. (error bars). *, p, 0.05; ***, p, 0.001; one-way ANOVAwith Sidak’s post
hoc test.
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Experimental procedures
Animals
All n numbers refer to the number of animals or the number
of individual cell culture preparations. Animal protocols were
performed in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and the Ani-
mals (Scientific Procedures) Act 1986 and approved by both
the Institutional Animal Care and Use Committee of Tufts
University and the Animal Services Unit at Bristol University.
Myc-pHluorin GABAAR a2 knock-in (pHa2) mice have been
described previously (22).
Primary neuronal cultures
Cultures were prepared from fetuses at embryonic day 18
from pregnant Wistar rats. Pregnant dams were sacrificed by
approved Schedule 1 methods. Hippocampi and cortices were
extracted and washed with Hanks’ balanced salt solution
(Gibco) and incubated with trypsin (Gibco) for 9 or 15 min,
respectively. Cells were further washed with Hanks’ balanced
salt solution and then dissociated with plating medium (1%
penicillin/streptomycin (Sigma), 2% B27 (Gibco), 2 mM Gluta-
Max (Gibco), and 5% horse serum (HS; Gibco) in Neurobasal
medium (Gibco)). 190,000 hippocampal cells were plated on
poly-L-lysine (Sigma)–treated coverslips in plating medium.
500,000 cortical cells were plated on poly-L-lysine–treated
dishes in plating medium before being placed in a humidified
incubator (37 °C, 5% CO2). Two hours after plating neurons,
platingmediumwas replaced with feedingmedium (1% penicil-
lin/streptomycin, 2% B27, and 800mMGlutaMax in Neurobasal
medium). After 7 days, 1 ml of feeding medium was supple-
mented to each dish.
Hippocampal slice preparation
Transverse slices were prepared from 8-week-old male WT
and pHa2 mice. Brains were quickly removed from isoflurane-
anesthetized mice and put in ice-cold sucrose-based cutting so-
lution containing 87 mM NaCl, 3 mM KCl, 7 mM MgCl2s?6H2O,
1.25 mM NaH2PO4, 0.5 mM CaCl2, 25 mM NaHCO3, 50 mM su-
crose, and 25 mM glucose. 400 mM slices were cut with a vibra-
tome (VT1000S, Leica Microsystems) and were allowed to
recover for 1 h in warm (35 °C), oxygenated (95% O2, 5% CO2)
artificial cerebrospinal fluid solution containing 126 mM NaCl,
2 mM MgCl2, 2 mM CaCl2, 2.5 mM KCl, 1.25 mM NaH2PO4, 26
mM NaHCO3, 1.5 mM pyruvate, 1 mM L-glutamine, and 10 mM
glucose.
Antibodies for Western blots
The phospho-a2 Ser-359 antibody was produced by Phos-
phoSolutions (Aurora, CO, USA). The following antibodies
were used forWestern blotting: anti-GABAAR a2 (1:500, Phos-
phosolutions, #822-GA2C), anti-collybistin (1:500 or 1:2000,
Synaptic Systems, #261-003), anti-gephyrin (1:1000–1:8000,
C13B11, Synaptic Systems, #147111), anti-GFP (1:1000 or
1:10,000, Synaptic Systems, #132002), and anti-horseradish
peroxidase–conjugated secondary antibody (1:10,000, Jackson
Immunoresearch, #715035150 and #715035152).
Antibodies for imaging
Antibodies for imaging were as follows: anti-gephyrin
(1:1000; Synaptic Systems, #147021), anti-Ankyrin G (1:1000;
Synaptic Systems, #386003), anti-GFP (1:5000; Abcam,
#ab13970), anti-chicken Alexa 488 (1:3000; Life Technologies,
Inc., #A11039), anti-mouse Alexa 568 (1:2000; Life Technolo-
gies, #A11004), and anti-rabbit Cy5 (1:1000; Stratech, #711-
175-152-JIR).
Expression constructs
Rat a2 was cloned from cDNA derived from rat cortical cul-
tures and cloned into pcdna3.1(2) with primers CAC CTC
GAG GCC ACC ATG AGG ACA AAA TTG AGC ACT TGC
(forward) and CAC GGA TCC TCA AGG ACT AAC CCC
TAA TAC AGG (reverse). For pHa2 in pcdna3.1(2), pHluorin
was inserted between amino acids 4 and 5 of rat Gabra2 (22) by
amplifying megaprimers with primers TGG TGC TGG CTA
ACA TCC AAG AAA GTA AAG GAG AAG AAC TTT TC
(forward) and GGT GAT ATT ATT TTT AGC CTC ATC
TTTGTATAGTTCATCCATGCC (reverse). shRNA-resist-
ant pHa2 was generated by the mutation of the third base of
three consecutive codons with primers T ATCGCTGTTTGT
TAC GCC TTC GTC TTC TCT GCC TTA ATT GAA (for-
ward). Site-directed mutagenesis was used to create phoshomi-
metic and phosphonull mutants: S359A, primer GAC AAG
AAA AAA GAG AAA GGC GCC GTC ATG ATA CAG AAC
AACG; S359D, primer GACAAGAAAAAAGAGAAAGGC
GAC GTC ATG ATA CAG AAC AAC G. pHa2 in pcdna3.1
(2) was cloned into a lentiviral vector pXLG3 WPRE px (45)
under the SFFV promoter: CAC ACT AGT GCC ACC ATG
AGG ACA AAA TTG AGC ACT TGC (forward) and CAC
GGA TCC TCA AGG ACT AAC CCC TAA TAC AGG
(reverse). Knockdown constructs were cloned into the pXLG3
vector under the H1 promoter (short hairpin shGabra2 target
sequence, GCG TTT GTG TTC TCT GCC TTA; nonspecific,
AAC GTA CGC GGA ATA CTT CGA). For GST fusion, the
GST-GABAAR a2 construct encoding the large intracellular
loop of the subunit was made from the full-length rat construct
mentioned above using primers CAC GAA TTC AAT TAC
TTC ACG AAA AGA GGA TGG (forward) and CAC CTC
GAGTCTGTCGATTTTGCTGACACTGTT (reverse).
MS analysis
pHa2 was immunoprecipitated from 8–10-week-old mice
with GFP-Trap as described previously (22). Trypsin and chy-
motrypsin digestion, LC–MS/MS, and data analysis were per-
formed by the Taplin Mass Spectrometry Facility (Harvard)
using peak list–generating software, ReAdW.exe (version
4.3.1), search engine SEQUEST (version 28, rev 13). In all cases,
enzymes were not specified for the search. Peptides were fil-
tered based on SEQUEST scores (XCorr and DCn) and mass
accuracy. Peptides were required to be tryptic, although there
were no filters specified for chymotrypsin. Fixed modifications
considered were 57.0215 Da on cysteine. Variable modifica-
tions considered were methionine oxidation (15.9949 Da) and
phosphorylation on serine, threonine, and tyrosine (73.9663
Da). The mass tolerance was set to 2 Da for precursor ions and
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1 Da for fragment ions. The threshold for accepting individual
spectra was that the precursor ppm values were ,5 ppm from
expected, along with manual interpretation. Peptides produced
by trypsin would be required to be tryptic peptides. The mini-
mum XCorr values for peptides charged 11, 12, 13, and 14
were .1.5, .1.5, .1.5, and .2, respectively. Each phospho-
peptide was analyzed using the Ascore algorithm to determine
the confidence of a given phosphorylation site (23). Sites were
confidently assigned when Ascore values were.13 (p, 0.05).
GST fusion protein production and pulldown assay
GST fusion proteins were produced as described previously
(22). 19 DIV rat cortical neuronal lysates were incubated with
GST fused to the large intracellular loop of GABAAR a2 as per-
formed previously (22). GST pulldown assays for gephyrin uti-
lized 500 mg of neuronal lysate/condition, and 2% input was
loaded; for collybistin, 750 mg of neuronal lysate was utilized
per condition, and 4% input was loaded.
Kinase assay and phosphopeptide mapping
GST, GST-a2 WT, and GST-a2 S359A immobilized on
GSH-Sepharose beads (GE Healthcare) were phosphorylated
with 10 mCi of [g-32P]ATP (BLU502A, PerkinElmer Life Scien-
ces) and 15 mg of brain lysate (as a source of kinase) for 7 min at
30 °C. Protein samples were separated by SDS-PAGE and
visualized by autoradiography. Bands were analyzed with
ImageJ (National Institutes of Health). Phosphopeptide map-
ping was performed as described (46). Briefly, 32P-labeled bands
from kinase assays were excised, dried, and digested with tryp-
sin (0.3 mg/ml in 50 mM NH4HCO3). Samples were spotted on
a cellulose TLC plate and subjected to two-dimensional phos-
phopeptide mapping, first by electrophoresis and then by
ascending chromatography. Dried TLC plates were exposed to
X-ray film. To detect phosphorylation by PKA, GST-a2 WT
and GST-a2 S359A immobilized on GSH-Sepharose beads
were incubated (30 °C, 30 min) with 0.75 mg of PKA catalytic
subunit (New England Biolabs) and NEBuffer for protein ki-
nases supplemented with 200 mM ATP (New England Biolabs).
Beads were washed four times (2500 3 g, 2 min, 4 °C) in lysis
buffer (described below) with 0.1% SDS.
Immunoprecipitation (IP)
To detect phosphorylated Ser-359 after okadaic acid (Tocris)
and forskolin (Tocris)/myristoylated-PKI treatment (Tocris),
mouse brain/rat neuronal cells were lysed with lysis buffer con-
taining 20 mM Tris-HCl, pH 8, 130 mM NaCl, 1% Triton X-100,
5 mM EDTA, 10 mM NaF, 2 mM Na3VO4, 10 mM Na4P2O7 and
supplemented with 0.1% SDS. Samples were spun at 16,1003 g
for 20min at 4 °C, and the supernatant (or lysate) was incubated
with GFP-Trap (Chromotek) overnight, followed by four quick
washes (2500 3 g, 2 min, 4 °C) in 1.5 ml of lysis buffer (with
0.1% SDS). To detect bound gephyrin and collybistin, neurons
were lysed and solubilized in lysis buffer, supplemented with
protease inhibitors (cOmplete, Roche Applied Science). Sam-
ples were spun at 16,100 3 g for 20 min, and lysate was incu-
bated with GFP-Trap overnight, after which beads were quickly
washed four times (2500 3 g, 2 min, 4 °C) in 1.5 ml of lysis
buffer. Bound proteins were detected by Western blotting. For
coimmunoprecipitations, 2% input was loaded, and 500 mg or 2
mg of neuronal lysate was used per immunoprecipitation
experiment for gephyrin and collybistin, respectively.
Western blotting and analysis
Proteins separated by SDS-PAGE (8 or 10% gel) were trans-
ferred to polyvinylidene difluoride membranes and blocked
with 6% milk in PBST for 1 h. Membranes were incubated in
primary antibody (1 h, 5% milk), followed by three 5-min
washes, before incubation with horseradish peroxidase–conju-
gated secondary antibodies for 1 h. After a further five 5-min
washes, blots were developed on film (CL-Xposure, Thermo
Scientific). For membranes incubated with phosphorylated and
nonphosphorylated peptides, 2 mg of peptide were added to
primary antibodies. Collybistin exists in multiple isoforms (25,
26) and appears as a doublet in immunoblots. For the purposes
of analysis, both bands were taken into account. Films were an-
alyzed using ImageJ. Multiple comparisons were performed
with one-way ANOVA followed by Tukey’s post hoc test. Post
hoc p values are stated in the text, and one-way ANOVA F and
p values can be found in Fig. S3.
Neuronal transfection
Hippocampal neurons were Lipofectamine 2000 (Invitrogen)
transfected at 15 DIV. Neuronal coverslips were rinsed in plain
Neurobasal medium and transferred to fresh dishes with 1 ml
of prewarmedNeurobasal medium and placed in the incubator.
Two tubes containing 200 ml of Neurobasal medium were pre-
pared. In tube 1, 1 mg of DNA and in tube 2, 1.5 ml of Lipofect-
amine were added. Both tubes were vortexed and incubated at
room temperature for 5 min, after which tubes were mixed to-
gether and incubated at room temperature for a further 20 min
to allow complex formation. The transfection mix was added to
cells and placed in the incubator for 45 min, after which they
were rinsed with Neurobasal medium. Coverslips were replaced
into their original dishes and left in the incubator until required.
Immunocytochemistry
At 19 DIV, neurons were fixed in 2% formaldehyde, 5% su-
crose solution in HBS: 20 mM HEPES, pH 7.4, 150 M NaCl, 5
mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 5 mM glucose for 20
min. After three quick washes in HBS, coverslips were incubated
with 50 mMNH4Cl for 10 min. After a further three quick washes
withHBS, coverslips were blocked and permeabilized in 0.1%Tri-
tonX-100, 1%BSA, 10%HS inHBS for 1 h. Neurons were stained
with primary antibodies overnight (0.1% Triton X-100, 1% BSA,
2% HS in HBS at 4 °C) and washed three times for 10 min with
HBS (supplemented with 0.1% Triton X-100) before incubating
and staining with secondary antibodies for 1.5 h. Coverslips were
washed three times for 10 min in HBS (supplemented with 0.1%
Triton X-100) and once in HBS before being mounted on slides
(Fluoromount-G, Southern Biotech).
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Image acquisition and analysis
Images were captured on a confocal laser-scanning micro-
scope (SP5-AOBS, Leica Microsystems) attached to an inverted
epifluorescence microscope (DMI 6000, Lecia Microsystems)
with a363, numerical aperture 1.4, oil immersion objective (Plan
Apochromate BL, Leica Microsystems). High-resolution images
(2048 3 2048, mean 2) were taken as a z-series of an average of
;7-8 z-stacks, taken at 0.5-mm intervals. Acquisition parameters
were kept the same for all scans within each experiment. Images
were collecting using the SP5 system’s acquisition software, and
analysis was performed using ImageJ software (47, 48). Image
stacks were projected using a maximum projection algorithm.
For each neuron, one 20-mm section of axon initial segment and
one or two 20-mmsections of secondary dendrites were analyzed.
Clusters of pHa2 on theAISweremeasured if they were localized
with the ankyrin Gmarker. Clusters on the dendrite were consid-
ered synaptic if colocalized or apposed to gephyrin puncta. To
examine the GABAAR a2 puncta, clusters were manually out-
lined, and their area wasmeasured by ImageJ. Cluster density was
defined as the number of puncta/mmof AIS or dendrite.Multiple
comparisons were performed with Kruskal–Wallis or one-way
ANOVA followed by Sidak’s post hoc test. Post hoc p values are
stated in the text, and Kruskall–Wallis and one-way ANOVA H,
F, and p values can be found in Fig. S3.
Lentiviral production
Lentivirus was produced in HEK293T cells maintained in
DMEM (D5796, Sigma) supplemented with 10% fetal bovine
serum (F7524, Sigma) (45). Briefly, cells were washed with plain
DMEM, polyethyleneimine transfected with 10 mg of lentiviral
transfer plasmid pXLG3 WPRE px encoding the expression or
knockdown of the protein of interest, 7.5 mg of packaging plas-
mid pD8.9, and 2.5 mg of envelope plasmid pMD2.G. After 4 h,
transfection medium was replaced with complete HEK me-
dium or neuronal feeding medium. Viral particles were har-
vested after;48 h, spun at 30003 g for 10 min, dispensed into
single-use aliquots, and stored at280 °C until use.
Data availability
The MS proteomics data have been deposited to the Proteo-
meXchange Consortium via the PRIDE partner repository (49)
with the data set identifier PXD019597.
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